Green Biologics Ltd (GBL) is a renewable chemicals company based in Abingdon, England with a wholly owned U.S. operating company, Green Biologics Inc., based in Gahanna, Ohio. GBL’s Clostridium fermentation platform converts a wide range of sustainable feedstocks into high performance green chemicals such as n-butanol, acetone, and through chemical synthesis, derivatives of butanol and acetone used by a growing global consumer and industrial products customer base. The platform combines advanced high productivity fermentation with superior-performing proprietary Clostridium microbial biocatalysts and synthetic chemistry to produce a pipeline of high value green chemicals with optimal performance in downstream formulations. Green Biologics was named to the Global Cleantech 100 list of the top Cleantech companies in the world for 2014 and 2015. The company was also #8 on the Hottest 40 Small Companies in the Bioeconomy and #22 on the Hottest 30 list for Bio-based Chemicals and Materials for 2015. Green Biologics is transforming the global specialty chemicals market, providing its customers with products and technology that are more sustainable and higher value than petroleum-based alternatives.